Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity
Researchers at the University of Bayreuth have, for the first time, deciphered key steps in the biosynthetic mechanism of the potential anti-cancer agent fostriecin. The team led by Prof. Dr. Frank Hahn has succeeded in producing ...